| The Impact of Remimazolam Tosilate on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy (NCT07086911) | Jinqiao Qian | 2025-08-01 |
| Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC (NCT07085169) | Ruijin Hospital | 2025-08-01 |
| Use of Pyrvinium to Reverse Stomach Precancerous Conditions (NCT06782048) | National University Hospital, Singapore | 2025-08-01 |
| Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma (NCT06045195) | University of Cologne | 2025-08-01 |
| Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia (NCT07101497) | The First Affiliated Hospital of Soochow University | 2025-08-01 |
| Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH (NCT07204041) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-08-01 |
| Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia (NCT06946511) | Ruijin Hospital | 2025-08-01 |
| Omega-3D: Omega-3 for Diet-Driven Health Disparities (NCT07078344) | University of Arizona | 2025-07-31 |
| Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus (NCT07096193) | Gilead Sciences | 2025-07-31 |
| Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis (NCT07052097) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-07-31 |
| Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma (NCT06905509) | University of California, Davis | 2025-07-31 |
| Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel (NCT07163819) | Universiti Sains Malaysia | 2025-07-31 |
| 177LuPSMA in Renal Cell Carcinoma (NCT06964958) | Dana-Farber Cancer Institute | 2025-07-31 |
| Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy (NCT06903923) | University of Virginia | 2025-07-31 |
| A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD (NCT07016412) | Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA | 2025-07-31 |
| Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC (NCT07172386) | Tianjin Medical University Second Hospital | 2025-07-31 |
| Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors (NCT07146672) | Shanghai Cell Therapy Group Co.,Ltd | 2025-07-31 |
| A Study of Tarlatamab for People With Prostate Cancer (NCT07111507) | Memorial Sloan Kettering Cancer Center | 2025-07-31 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. (NCT07058662) | Belief BioMed (Beijing) Co., Ltd | 2025-07-31 |
| A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC (NCT07086326) | Yang Fan, MD | 2025-07-31 |
| Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC (NCT07070713) | Fujian Cancer Hospital | 2025-07-30 |
| Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC (NCT07085234) | The First Affiliated Hospital of Xiamen University | 2025-07-30 |
| The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia (NCT07064889) | Peking University People's Hospital | 2025-07-30 |
| A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia (NCT06721013) | Eli Lilly and Company | 2025-07-30 |
| Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) (NCT06780111) | Merck Sharp & Dohme LLC | 2025-07-30 |
| Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA (NCT07161336) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2025-07-30 |
| Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial (NCT06949228) | ProMedica Health System | 2025-07-30 |
| Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8) (NCT07079475) | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | 2025-07-30 |
| A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies (NCT07024784) | AbbVie | 2025-07-30 |
| A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma (NCT06902389) | Eastern Hepatobiliary Surgery Hospital | 2025-07-30 |
| Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN (NCT06949436) | University of Alberta | 2025-07-30 |
| A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months (NCT07126262) | BioMarin Pharmaceutical | 2025-07-30 |
| Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma (NCT07019181) | The First Affiliated Hospital of Xiamen University | 2025-07-30 |
| Mindfulness-Assisted Psychedelic Therapy (NCT06233344) | University of Southern California | 2025-07-30 |
| First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury (NCT06922890) | Yonsei University | 2025-07-30 |
| Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. (NCT07121322) | National Cancer Institute, Slovakia | 2025-07-30 |
| TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer (NCT07044908) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-07-30 |
| A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment (NCT06772233) | Peking University | 2025-07-30 |
| A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma (NCT07124936) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-07-30 |
| SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors (NCT07022002) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2025-07-30 |
| RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses (NCT07002034) | Reunion Neuroscience Inc | 2025-07-30 |
| SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures (NCT07141329) | Supernus Pharmaceuticals, Inc. | 2025-07-30 |
| Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC (NCT06897046) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-07-30 |
| DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy (NCT07024693) | Design Therapeutics, Inc. | 2025-07-30 |
| Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II) (NCT07134790) | University Ghent | 2025-07-30 |
| Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (NCT07061535) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-07-30 |
| High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients (NCT07094724) | Gili Regev-Yochay MD | 2025-07-30 |
| A Study to Investigate Safety and Preliminary Efficacy of SOA101 in Adult Subjects With Advanced Solid Tumors (NCT07055594) | Shine-On Biomedical Co., Ltd. | 2025-07-30 |
| Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy (NCT06680596) | UNICANCER | 2025-07-30 |
| Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study (NCT07064668) | Tongji Hospital | 2025-07-30 |
| Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder (NCT04737603) | University of California, Davis | 2025-07-30 |
| A Study With CIT-013 in RA Patients (NCT06567470) | Citryll BV | 2025-07-29 |
| A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC (NCT06294548) | University of Alabama at Birmingham | 2025-07-29 |
| A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity (NCT07081958) | Hoffmann-La Roche | 2025-07-29 |
| PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma (NCT07209059) | National Research Center for Hematology, Russia | 2025-07-29 |
| A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease (NCT06328608) | Chiesi Farmaceutici S.p.A. | 2025-07-29 |
| Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients (NCT07009171) | NeuroBiogen Co., Ltd | 2025-07-29 |
| PALACE: Cemiplimab Trial According to ctDNA Levels (NCT06917573) | Fundación GECP | 2025-07-29 |
| Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC (NCT07088211) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2025-07-29 |
| A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors (NCT07115043) | AstraZeneca | 2025-07-29 |
| Iparomlimab and Tuvonralimab in HNSCC (NCT07090317) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2025-07-29 |
| External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer (NCT06543576) | Jonsson Comprehensive Cancer Center | 2025-07-29 |
| Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users (NCT07083635) | Chulalongkorn University | 2025-07-29 |
| A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis (NCT06909136) | Suzhou Junjing BioSciences Co., Ltd. | 2025-07-28 |
| A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer (NCT06962787) | Sichuan Baili Pharmaceutical Co., Ltd. | 2025-07-28 |
| Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study (NCT06580444) | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2025-07-28 |
| EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) (NCT07047703) | Grey Wolf Therapeutics | 2025-07-28 |
| STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1 (NCT07038915) | M.D. Anderson Cancer Center | 2025-07-28 |
| A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients (NCT07331402) | Haisco Pharmaceutical Group Co., Ltd. | 2025-07-28 |
| Chronic Exogenous Ketosis in HFpEF (NCT06937320) | Duke University | 2025-07-28 |
| A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) (NCT07073417) | Hangzhou Sciwind Biosciences Co., Ltd. | 2025-07-28 |
| NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment (NCT06537154) | Peter Black | 2025-07-28 |
| Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization (NCT07106580) | University of Rijeka | 2025-07-28 |
| Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study (NCT07000734) | Washington University School of Medicine | 2025-07-28 |
| Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer (NCT06959550) | M.D. Anderson Cancer Center | 2025-07-28 |
| Phase I/II Study of SCTB39G in Advanced Solid Tumours (NCT07077252) | Sinocelltech Ltd. | 2025-07-28 |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction (NCT06195306) | National Cancer Institute (NCI) | 2025-07-28 |
| Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST) (NCT07036406) | Teachers College, Columbia University | 2025-07-28 |
| Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy Ageing (NCT07112352) | Imperial College London | 2025-07-28 |
| Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. (NCT07148128) | Auricula Biosciences Inc. | 2025-07-28 |
| Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant (NCT06129734) | Benjamin Tomlinson | 2025-07-28 |
| Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) (NCT07055880) | Sinovac Biotech Co., Ltd | 2025-07-28 |
| Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL (NCT06838832) | Chinese PLA General Hospital | 2025-07-27 |
| A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy (NCT07282028) | Nuance Hearing | 2025-07-27 |
| Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer (NCT06295588) | University of Rochester | 2025-07-26 |
| BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases (NCT07062055) | Shandong Cancer Hospital and Institute | 2025-07-25 |
| Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes (NCT06791291) | Sanofi | 2025-07-25 |
| 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss (NCT07044310) | Mayo Clinic | 2025-07-25 |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder (NCT07046494) | Rapport Therapeutics Inc. | 2025-07-25 |
| Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer (NCT07045805) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-07-25 |
| A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (NCT06977568) | Pacira Pharmaceuticals, Inc | 2025-07-25 |
| Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma (NCT06723457) | Reem Karmali | 2025-07-25 |
| Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387 (NCT07010159) | Kiniksa Pharmaceuticals International, plc | 2025-07-25 |
| Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer (NCT06938724) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2025-07-25 |
| Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) (NCT06984328) | Genmab | 2025-07-25 |
| A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (NCT06859424) | Center for International Blood and Marrow Transplant Research | 2025-07-25 |
| Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study (NCT07089199) | Qilu Hospital of Shandong University | 2025-07-25 |
| Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis (NCT07039578) | Keymed Biosciences Co.Ltd | 2025-07-25 |
| Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer (NCT07017673) | Cedars-Sinai Medical Center | 2025-07-25 |
| An Efficacy and Safety Study of LTG-001 Following Abdominoplasty (NCT07102459) | Latigo Biotherapeutics | 2025-07-24 |